75 results
REBEL Review 4 & 5: Paralytic & Vasopressor Dosing 

Paralytic Agents:
 - Succinylcholine (Depolarizing Agent)
Paralytic Agents ... (Depolarizing Agent ... resuscitation #table ... #criticalcare # ... pharmacology #dosing #medications
FDA-Approved 1st line Medications for Tobacco Cessation Treatment

Nicotine patch, Nicotine lozenge, Nicotine gum, Nicotine inhaler, Nicotine
FDA-Approved 1st line Medications ... Tobacco Cessation Treatment ... , Varenicline (tablet ... release (SR) (tablet ... #Agents #Dosing
Brief Overview of Treatment Agents for COVID-19 - Version 2.01 4/11/2020

#Drugs #Medications #Treatment #COVID19 #Pharmacology #Table
Brief Overview of Treatment ... Agents for COVID ... 2020 #Drugs #Medications ... #Treatment #COVID19 ... #Pharmacology #Table
Topical drug formulations, comparison and considerations

#pharmacology #table #medications #comparison #drugs #treatment #pharmacotherapy #dermatology
#pharmacology #table ... #medications #comparison ... #drugs #treatment ... pharmacotherapy #dermatology
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
anti-hyperglycemic agents ... Each class of medications ... pharmacotherapy #table ... comparison #management #medications ... endocrinology #treatment
Here is a quick guide on the common direct-acting antivirals (DAAs) for chronic hepatitis C virus
DAAs #Antivirals #table ... #treatment #hcv ... #medications #infectiousdisease ... #hepatology #HepC
Approach to Thrombocytosis - Elevated Platelet Count - Differential Diagnosis Algorithm

Peripheral Smear concerning for malignancy?
- Differential Diagnosis ... Rebound effect from treatment ... myelosuppressive agents ... • Reaction to Medications ... #Differential #Diagnosis
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
For most indications ... #pharmacology #treatment ... #medications #table ... decisionaid #cardiology #hematology
COVID-19: ICU Guidelines for the Non-Intensivist
Infection Control
Risk Factors for Severe Disease
Initial Laboratory Workup
COVID-19 Specific Medications
Respiratory
Cardiac
Hematologic
Neuro/Sedation

#COVID19 #ICU
COVID-19 Specific Medications ... Respiratory Cardiac Hematologic ... #COVID19 #ICU #criticalcare ... NonIntensivist #diagnosis
Medications associated with neuroleptic malignant syndrome

First-generation and second-generation antipsychotics are dopamine receptor antagonists, which produce a
Medications associated ... single dose of an agent ... after years of treatment ... with the same agent ... #Diagnosis #Differential